Literature DB >> 24259053

WITHDRAWN: Pleurodesis for malignant pleural effusions.

Paul H S Shaw1, Roshan Agarwal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24259053     DOI： 10.1002/14651858.CD002916.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


× No keyword cloud information.
  3 in total

1.  Wet M1a non-small cell lung cancer: is it possible to predict recurrence of pleural effusion?

Authors:  Fernando Conrado Abrao; Igor Renato Louro Bruno de Abreu; Geisa Garcia Viana; Mariana Campello de Oliveira; Elnara Marcia Negri; Riad Naim Younes
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

2.  Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.

Authors:  Akash Verma; Akhil Chopra; Yeo W Lee; Lavina D Bharwani; Atasha B Asmat; Dokeu B A Aneez; Fazuludeen A Akbar; Albert Y H Lim; Sanjay H Chotirmall; John Abisheganaden
Journal:  Curr Drug Discov Technol       Date:  2016

3.  Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion.

Authors:  Akash Verma; Chee Kiang Phua; Wen Yuan Sim; Reyes Elmer Algoso; Kuan Sen Tee; Sennen J W Lew; Albert Y H Lim; Soon Keng Goh; Dessmon Y H Tai; Ai Ching Kor; Benjamin Ho; John Abisheganaden
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.